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In this paper we present cellular senescence as the ultimate driver of the aging process,
as a “causal nexus” that bridges microscopic subcellular damage with the phenotypic,
macroscopic effect of aging. It is important to understand how the various types of
subcellular damage correlated with the aging process lead to the larger, visible effects
of anatomical aging. While it has always been assumed that subcellular damage (cause)
results in macroscopic aging (effect), the bridging link between the two has been hard
to define. Here, we propose that this bridge, which we term the “causal nexus”, is
in fact cellular senescence. The subcellular damage itself does not directly cause the
visible signs of aging, but rather, as the damage accumulates and reaches a critical
mass, cells cease to proliferate and acquire the deleterious “senescence-associated
secretory phenotype” (SASP) which then leads to the macroscopic consequences of
tissue breakdown to create the physiologically aged phenotype. Thus senescence is a
precondition for anatomical aging, and this explains why aging is a gradual process that
remains largely invisible during most of its progression. The subcellular damage includes
shortening of telomeres, damage to mitochondria, aneuploidy, and DNA double-strand
breaks triggered by various genetic, epigenetic, and environmental factors. Damage
pathways acting in isolation or in concert converge at the causal nexus of cellular
senescence. In each species some types of damage can be more causative than
in others and operate at a variable pace; for example, telomere erosion appears to
be a primary cause in human cells, whereas activation of tumor suppressor genes is
more causative in rodents. Such species-specific mechanisms indicate that despite
different initial causes, most of aging is traced to a single convergent causal nexus:
senescence. The exception is in some invertebrate species that escape senescence,
and in non-dividing cells such as neurons, where senescence still occurs, but results
in the SASP rather than loss of proliferation plus SASP. Aging currently remains an
inevitable endpoint for most biological organisms, but the field of cellular senescence
is primed for a renaissance and as our understanding of aging is refined, strategies
capable of decelerating the aging process will emerge.
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INTRODUCTION
Until recently the biology of aging may have appeared to be
hopelessly complex, but we can nevertheless apply a strictly
rational approach toward solving the problem: what is the
overarching, fundamental basis of biological aging? There must
be a foundational reason for aging that leads to the eﬀects that we
observe at the macroscopic, organismal level.
In 1881 the evolutionary biologist August Weismann took
such a rational approach and proposed that “Death takes place
because a worn-out tissue cannot forever renew itself, and
because a capacity for increase by means of cell division is
not everlasting but ﬁnite.” How did he arrive at such a bold
conclusion? Weismann observed that during evolution, simple
multicellular organisms such as Pandorina Morum, which were
immortal, gradually evolved into mortal organisms such as
Volvox Minor (West, 2003). The absolutely crucial diﬀerence
between these two organisms is that while Pandorina’s cells were
undiﬀerentiated and divided without limit, Volvox’s cells had
diﬀerentiated into two very diﬀerent types: the Soma (body) cells,
and the Germ (reproductive) cells (Figure 1). Thus, while the
germ line has retained the capacity for inﬁnite renewal, the body
cells (soma) have not; they age and expire.
Life on earth has been perpetuated for billions of years
throughout evolution, sustained by imperishable germ line cells,
but individual organisms perish after each generation because
somatic cells cannot divide indeﬁnitely (Figure 2). Closer analysis
reveals that in biological systems, the variability in proliferative
capacity of diﬀerent types of somatic cells from diﬀerent species
is exhibited over a wide range, from very limited to extensive. But
nevertheless, the immortality inherent in the earliest unicellular
organisms evolved into complex, mortal multicellular organisms
that acquired an “aging phenotype” over the course of their life
spans (Petralia et al., 2014).
While Weismann’s hypotheses were remarkably prescient,
at that time neither DNA nor cultured cells were suﬃciently
FIGURE 1 | The evolution of cellular diversity as the origin of cellular
senescence. Pandorina morum on the left, which is immortal, has a single
cell type; whereas the mortal Volvox minor on the right has two distinct cell
types representing the immortal germ line and the mortal soma in the same
multicellular organism. Only the immortal germline cells in Volvox can produce
the next generation (Figure adapted from West, 2003).
FIGURE 2 | The dichotomy of germ line and soma: organismal
diversity. The figure represents the evolution of complex organisms from
simpler forms through the immortal germline. Each species is capable of
self-propagation only through the germ line, and this has evolved and given
rise to increasingly complex organisms from the simple organism like Volvox
to the most complex such as Homo sapiens. It represents the co-existence of
cellular immortality and mortality in the same organism (Figure adapted from
West, 2003).
understood to allow his theory to be adequately tested. In fact,
it was not until nearly one hundred years later, following the
development of sophisticated animal cell culture protocols, that
he was proven correct: it was shown that somatic cells grown
in culture have limited growth potential. After approximately
forty passages, human cells stop proliferating and undergo
cellular senescence (Hayﬂick and Moorhead, 1961; Hayﬂick,
1994). A clear picture has since emerged: somatic cells are mortal,
but germ cells are not. Organismal aging begins with a gradual
yet consistent decline in cell proliferation of the somatic cells.
The macroscopic outcome is evidenced by the appearance of
dysfunctional and “worn out” tissues that degrade continuously,
ﬁnally resulting in structural instability and death of the organism
(Weismann, 1891).
In the context of modern cell biology, we can extend
Weismann’s ideas a little further: recent ﬁndings based on cell-
fate determination from progenitor cells of variable levels of
pluripotency indicate that living organisms are composed of a
hierarchy of both limited-capacity somatic and progenitor cells,
and high division-capacity stem cells, in addition to immortal
germ cells. Emergence of a cancer cell occurs through neoplastic
transformation and acquisition of cellular immortality, albeit in
a corrupted genetic and epigenetic state, while emergence of an
aged cell occurs through the induction of cellular senescence
(Figure 3). Somatic cells divide in vivo for a limited number
of cycles, and their cell-division potential is tissue-speciﬁc and
variable. For instance, intestinal crypt somatic stem cells have
greater replicative limits than other types of cells of similar
heritage (Potten and Loeﬄer, 1990). Importantly, tissue-speciﬁc
cell lines replicate with similar potential in vitro (Schneider and
Mitsui, 1976).
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FIGURE 3 | The dichotomy of germ line and soma: aging and neoplastic transformation. Totipotent embryonic stem cells give rise to both germ cells and
somatic stem cell progenitors with defined self-renewal potential. Somatic progenitors divide and proliferate into tissue-specific terminally differentiated cells with
limited self-renewal potential that decreases with age, and they enter senescence in response to external and internal cues. The growing population of senescent
cells lead to withered tissue and organismal aging, but deregulation of proliferation arrest as well as secretion of proinflammatory cytokines has pro-oncogenic effects
that can trigger neoplastic transformation, evident with the appearance of cancer stem cells; their further aggressive division leads to tumorigenesis.
Besides Weismann’s evolutionary theory, many additional
theories have been proposed to explain the complexity of aging.
These include the antagonistic pleiotropy theory (Williams,
1957), the free radical theory, age-associated shortening of
telomeres, development of insulin resistance, decreased immune
function, the mitochondrial theory, as well as deregulation
of the circadian clock (Campisi, 2013). While these theories
indicate functional diversity in the etiology of aging, it must
be stressed that each one relies on the concept of internal
alterations in individual cells, and does not explain how
the microscopic cellular damage manifests as macroscopic
aging and tissue breakdown in the organism (with a few
exceptions, such as changes in hormone function and declines
in immune function). Theories of mutation accumulation and
antagonistic pleiotropy address the genetic causes of aging, and
environmental stress or lack of it contributes to modulation of
the epigenome as well as physiological alterations in diﬀerent
tissues of the whole organism, but each theory revolves
around the functional competence of diﬀerent components
of cells and again does not explain how this manifests as
macroscopic organismal aging. Experimental evidence unifying
the interactions of some components has started to emerge
(Kelly, 2011; Sahin et al., 2011), but we propose that all of the
changes described by diverse theories ultimately converge on
the cellular senescence theory. However, before we describe this
evidence, we will ﬁrst describe exactly what we mean by cellular
senescence.
THE SENESCENT PHENOTYPE
Molecular Characteristics of Cellular
Senescence
Cellular senescence was ﬁrst referred to as the “Hayﬂick
limit” based on its discovery in ﬁbroblasts by Dr. Leonard
Hayﬂick (Hayﬂick, 1965). It has been deﬁned as a process
limiting somatic cell proliferation that acts by disrupting cell
division, usually entailing loss of replication of nuclear DNA
with elevated expression of multiple tumor suppressor proteins
(Shay et al., 1991; Rowland et al., 2002). Crucially, and this is
important to emphasize, cellular senescence diﬀers from “loss
of proliferation” or “quiescence” in that it also includes the
cellular responses to stress, such as altered gene expression
and metabolic activity, as well as accumulated insults that lead
to and trigger irreversible arrest. Senescence is additionally
characterized by resistance to apoptosis, interference with cellular
diﬀerentiation, and alteration of cellular function (Moiseeva et al.,
2006). Another major hallmark of senescence is the senescence-
associated secretory phenotype (SASP), whereby cells convert
into their proinﬂammatory counterparts that promote pathology
by secreting various proteins that have deleterious eﬀects on
the tissue microenvironment. It is important to realize that
while senescence cannot result in loss of proliferation in non-
dividing cells such as skeletal muscle cells and neurons, such cells
nevertheless undergo a major conversion to the SASP (Salminen
et al., 2011).
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Since the aforementioned discovery in ﬁbroblasts by Hayﬂick
(1994), we now know that multiple cell types including
keratinocytes, endothelial cells, lymphocytes, adrenocortical cells,
vascular smooth muscle cells, chondrocytes, and many others
acquire senescent phenotypes over time (Rodier and Campisi,
2011). It is an almost universal phenomenon in somatic cells,
observed in diverse animal species including mice, chickens,
humans and tortoises, and occurs in cells of all ages, from
embryonic to adult tissues regardless of donor age (Hayﬂick,
1994). Nevertheless, some invertebrate animals such as sea
urchins appear to have escaped the senescencemechanism, which
may be an important area for future research (Francis et al., 2006;
Bodnar, 2015).
Senescence Biomarkers
Morphologically, senescent cells expand in size, acquiring
enlarged nuclei, a prominent Golgi apparatus and a vacuolated
cytoplasm (Hayﬂick and Moorhead, 1961). In the absence
of DNA replication, metabolically active senescent cells
are identiﬁed by enlargement of lysosomes accompanied
by increased lysosomal β-galactosidase (Kurz et al., 2000;
Lee et al., 2006) commonly termed “senescence associated
β-galactosidase” (Dimri et al., 1995). In addition to expression
of β-galactosidase, most senescent cells also express the tumor
suppressor p16INK4a, a factor not commonly seen in quiescent
or terminally diﬀerentiated cells (Alcorta et al., 1996; Hara
et al., 1996; Stein et al., 1999). Besides p16INK4a, other robust
biomarkers of the senescent phenotype are p21/waf1/cip1, p27
and p53 (Shay, 1999). Initiation of autonomous senescence
by p16INK4a has also been reported (Dai and Enders, 2000).
Senescence-associated heterochromatin foci (SAHF) are another
marker that occur in a cell type- and insult-dependent manner
and follow expression of p16INK4a, but appear to be dispensable
for cellular senescence (Kosar et al., 2011). While RNA binding
proteins (RBPs) exhibit abundant expression in all tissues and
age-groups, their expression level sharply declines in senescent
cells (Masuda et al., 2012).
The course of senescence is initiated by events such as
inhibition of Cdk–cyclin activity through the aforementioned
p16INK4a and/or p21, or by alteration of p53 expression that
triggers transition from a temporary to a stable cell cycle arrest.
Cell-cycle arrest is followed by a state of early senescence marked
by lamin B1 down-regulation, marked chromatin remodeling,
and SASP production. A true senescent phenotype follows, with
the onset of histone proteolysis or replacement and chromatin
budding. Finally, the cell terminates in late senescence driven by
additional genetic and epigenetic alterations (Shelton et al., 1999;
De Cecco et al., 2011; Shah et al., 2013).
Aging: A Progression of Scale
Once these microscopic events reach a threshold and converge
to trigger cellular senescence, the impact then graduates from
the subcellular to the tissue level. This picture of aging therefore
depends on a progression of scale from small and invisible
microscopic damage to larger cellular damage that ultimately
results in expression of a highly visible, comprehensively aged
phenotype of tissue breakdown throughout the body of the
organism. In other words, the causal nexus linking the indirect
causes of aging (microscopic damage) with the direct eﬀects of
aging (macroscopic) is cellular senescence. And as we move from
the microscopic subcellular damage through cellular senescence
to macroscopic aging and tissue malfunction, we simultaneously
move from causes, to causal nexus, to ﬁnal eﬀect. It is important
to understand that in this model, the visible macroscopic
manifestations of aging will not become apparent until cells start
to senesce, lose their ability to proliferate, and take on the SASP
phenotype.
Senescence as an Anticancer
Mechanism
Prior to discussing the diverse types of microscopic damage
that trigger senescence, it is important to emphasize the
relationship between senescence and cancer, since cancer is also
a pathological outcome resulting from damaged DNA (Campisi,
2001, 2013; Rodier and Campisi, 2011; Cerella et al., 2015).
Cancer is also accompanied by additional speciﬁc morphological
and molecular features including initially shortened telomeres,
unstable chromosomes and, temporarily, relatively low levels
of telomerase (Shay and Wright, 2010). Most important
conceptually, the onset of cancer is ultimately actualized by
cellular dysfunctions resulting from the bypass of pathways that
would normally induce senescence or apoptosis to prevent cancer
(Artandi and Attardi, 2005), (Figure 4). For example, inactivation
of tumor suppressors such as pRb and P53 and activation of
telomerase has been widely detected in many human cancers
(Figure 4). Such ﬁndings have prompted studies to delineate ﬁne
diﬀerences in pathways leading to apoptosis, cellular senescence
and cancer for therapeutic analysis, as well as to decelerate the
aging process (Cerella et al., 2015).
FACTORS CAUSING SENESCENCE
Now that we have described senescence, what are the diverse
types of microscopic damage that can cause such a state? They are
now known to be multiple (Salama et al., 2014), some of which
we describe in the following sections. This is not an exhaustive
list, but summarizes some of the key players. This section is also
summarized in Figure 5.
Telomere Shortening
Chromosomal structure, as described in this and subsequent
sections, is a major determinant of the proliferative ability of
cells. Telomeres are probably the most well-studied part thereof
because they make a signiﬁcant contribution to maintaining
chromosomal function, and their length is an accurate predicator
of the replicative ability of cells (Allsopp et al., 1992). Telomere
attrition is associated with senescence (Shay, 1999), and once
telomeres reach a critically short length they trigger a DNA
damage response, including p53 activation (Herbig et al., 2004;
Artandi and Attardi, 2005) that causes onset of cell-cycle arrest
and replicative senescence (Kudlow et al., 2008; Gonzalez-Suarez
et al., 2009; Benson et al., 2010). In somatic cells of humans and
mice, a tight regulation of telomere length and telomerase activity
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FIGURE 4 | Senescence is a tumor suppression mechanism, by
blocking proliferation of cancer cells, and promotes aging via loss of
macroscopic structure and “inflammaging”. Cancer cells must bypass
senescence to continue proliferating. A proliferating cell undergoes stress
from, e.g., damaged telomeres and oxidation, leading to activated
oncogenes. This leads to cellular senescence, characterized by loss of
proliferation, and activation of SASP and inflammation. In combination with
immune clearance this is a tumor suppression mechanism. Cancer cells must
somehow bypass senescence, i.e., through inactivation of p53 and pRb
and/or activation of telomerase, in order to continue proliferating.
is a signiﬁcant factor in maintaining balance between induction
of senescence and emergence of cancerous cells (Chang, 2005), as
well as regulation of life span (Henriques and Ferreira, 2012).
DNA Double-Strand Breaks and the DNA
Damage Response
Besides telomeres, long-term nuclear DNA damage, especially
DNA double-strand breaks, leads to a chronic DNA damage
response (DDR) signal, that includes activation of a wide range
of DDR proteins including p53, leading to senescence (Rodier
and Campisi, 2011; Fumagalli et al., 2012). Signals are important
for initiation of senescence in response to both short telomeres
(see above), and strand breaks, and are manifested as activated
DNA damage sensor and eﬀector proteins, localized to either
the dysfunctional telomeres (telomere dysfunction-induced foci,
TIFs) or other sites of DNA damage such as senescence-
associated DNA damage foci or SDFs (d’Adda di Fagagna et al.,
2003; Takai et al., 2003; Bartkova et al., 2006; Di Micco et al.,
2006). However, direct evidence for a causal relationship between
DNA breaks and senescence was lacking, due to the diﬃculty of
inducing deﬁned DNA lesions in cells without simultaneously
damaging other biomolecules and structures. Recently it was
discovered that DNA double-strand breaks (DSBs) alone can
create an aged phenotype by implementing an adenovirus-based
system based on controlled expression of the Sac I restriction
enzyme. The adenovirus was delivered to mice, and molecular
and cellular end points in the liver were compared with normally
aged animals. Treated mice displayed many signs of normal
liver aging as early as 1 month after treatment, including aging
pathologies, markers of senescence, fused mitochondria, and
alterations in gene expression proﬁles, showing that DSBs alone
can cause distinct aging phenotypes in mouse liver, and proving
the role of DNA damage as a driver of tissue aging via induction
of senescence (White et al., 2015).
Epigenetic Alterations
Epigenetic alteration, distinct from telomere, or mutational
damage, is another mechanism inducing cellular senescence.
Since the only diﬀerences between immortal germline cells and
mortal somatic cells (Figure 1) are changes in gene expression,
rather than changes in gene sequences themselves, it stands to
reason that a large component of aging is epigenetic in nature.
Furthermore, the epigenetic clock is reset or “rejuvenated” during
generation of induced pluripotent stem cells (Horvath, 2013).
A collection of recent studies have deﬁned both senescence
and youthfulness as being largely epigenetic states (Rando
and Chang, 2012; Horvath, 2013; Schellenberg et al., 2014;
Beerman and Rossi, 2015; Marioni et al., 2015). Continuous
methylation changes at six speciﬁc CpG sites of long term
cultured cells have been reported (Koch et al., 2012) and
in cultured human cells, senescence is accompanied by
simultaneous genome-wide DNA hypomethylation in gene-
poor, late replicating chromosomal regions and focal low-level
hypermethylation at CpG sites of genes that trigger cancer
pathways (Cruickshanks et al., 2013). In mouse cells, DNA
methylation proﬁling at CpG islands in promoters of expressed
autosomal genes revealed 21% hypermethylation and 14%
hypomethylation as a function of age; the data clearly indicate
epigenetic dysregulation as a contributing factor for senescence
inmammalian cells (Maegawa et al., 2010). Similar age-associated
distinct methylation alterations have been detected in the
CpG islands of promoters of genes regulating DNA binding
and transcription in human brain tissue (Hernandez et al.,
2011). Conversely, methylation-based enhanced ﬁdelity of gene
transcription has been shown to promote longevity (Sen et al.,
2015).
Recent work indicates that along with alteration of DNA
methylation at speciﬁc transcription factor binding sites, nuclear
reorganization is also correlated with replicative senescence
(Hänzelmann et al., 2015). Noted are extensive nuclear changes,
including chromatin remodeling, as integral steps in cellular
senescence (Baker and Sedivy, 2013). Relaxation of constitutive
heterochromatin and transcription of satellite DNA along with
enlargement of centromeres indicate an epigenetic impact on
chromosome integrity while perturbation of the epigenome
elicits cellular senescence (Berdasco and Esteller, 2012). Also,
broad-acting histone-deacetylase inhibitors exert signiﬁcant
epigenetic inﬂuence at the onset of senescence (De Cecco et al.,
2011).
Aneuploidy
In addition to DNA damage and epigenetic alterations, aberrant
chromosomal number, or aneuploidy also induces senescence
(Moiseeva et al., 2006), as does reduced expression of the mitotic
checkpoint protein, BubR1. Insuﬃciency of this protein leads
to age-associated pathology and infertility in mice (Baker et al.,
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FIGURE 5 | Cellular senescence and aging. The organismal life span is controlled by internal and external factors inducing senescence and therefore,
proliferation arrest. The text lists molecular and physiological triggers that may lead to: telomere attrition, aneuploidy, DDR response, epigenetic modulations, and
mitochondrial dysfunction; these are causes of senescence manifested as either loss of cellular proliferation and emergence of the senescent associated secretory
phenotype (SASP) in dividing cells, or simply SASP alone in non-dividing cells.
2004), whereas increased expression protects against aneuploidy
and cancer while extending the lifespan (Baker and Sedivy, 2013;
Baker et al., 2013). A p53-mediated mechanism regulates and
limits the propagation of aneuploidy in human cells (Thompson
and Compton, 2010).
Oxidative Stress and Mitochondrial
Dysfunction
Besides the diﬀerent types of nuclear alterations described
above, mitochondria are also closely linked to senescence.
This stands to reason, since insuﬃcient ATP renders the cell
incapable of producing suﬃcient energy to divide and replicate
itself. Likewise, oxidative stress generated by mitochondrial
dysfunction has been established as a contributing factor in aging
(Hayﬂick and Moorhead, 1961; Simonsen et al., 2002; Moiseeva
et al., 2006) as well as an outcome of cellular senescence (Passos
et al., 2007).
Most primary cell types are prone to senescence in response
to oxidative stress caused by reactive oxygen species (ROS)
primarily through telomere attrition (von Zglinicki, 2002), or
oncogene activation (Moiseeva et al., 2009). Results from the
treatment of human kidney epithelial cells with hydrogen
peroxide and the cell-cycle inhibitor apigenin separately showed
increased oxidative stress, mitochondrial dysfunction, apoptosis
and cellular senescence, and simultaneous treatment augmented
the detrimental eﬀects (Small et al., 2012).
A recent review of ﬁndings indicates that, in addition
to ROS, multiple mitochondrial signaling pathways can
induce senescence (Ziegler et al., 2015). For example,
reduction in ATP levels by dysregulation of glycolytic
enzymes leads to a drastic increase in AMP levels, which
induces premature senescence (Zwerschke et al., 2003).
Another study showed that a comparison of the global DNA
methylation proﬁle of replicative versus premature senescence
in lung ﬁbroblasts indicated that oxidative damage partially
induces senescence-associated epigenetic alterations (Zhang
et al., 2008), linking ROS with epigenetic alterations (see
above).
In addition to the physiological processes of mitochondrial
dysfunction, damage to mitochondrial DNA (mtDNA) itself
also contributes to the aging process through induction
and progression of senescence, as evidenced by studies
of mouse models with defective mtDNA polymerase that
cause accumulation of mutations in mitochondrial DNA
due to an impaired proof-reading function (Baines et al.,
2014). Damage to mtDNA in these mouse strains leads to
the induction of premature aging, evident in progenitor
cell malfunction beginning as early as embryogenesis.
This results in abnormal lineage diﬀerentiation (Ahlqvist
et al., 2012). Also, the proliferative ability of mouse
embryonic ﬁbroblasts has been conﬁrmed to be altered
by a rise in the mutational load in mtDNA (Kukat et al.,
2011).
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Inflammation, Energy Sensing, and
Altered Metabolic Regulation
Association of chronic inﬂammation with aging and age-
related pathological conditions has long been proposed (Freund
et al., 2010). A pro-inﬂammatory secretory phenotype termed
“inﬂammaging” is associated with senescence in all mammals
(Salminen and Kaarniranta, 2012). Along with the stress
response, activation of proinﬂammatory pathways activates
NF-κB in the hypothalamus, which in turn negatively inﬂuences
production of gonadotropin-releasing hormone that normally
stimulates neurogenesis in aging mice (Zhang et al., 2008).
These ﬁndings substantiate evidence of aberrant intercellular
communication triggered by secretory properties of senescent
cells (the SASP phenotype) responsible for inﬂuencing the
endocrine system. Protein kinase D1 has been found to regulate
RAS-induced oncogenic senescence by modulating NF-κB
activity and senescent-associated inﬂammation (Wang et al.,
2014). Interestingly, genetically induced progressive low grade
chronic inﬂammation through knockout of the nfkb1 subunit
of transcription factor NF-κB leads to telomere dysfunction,
eventually causing senescence (Jurk et al., 2014) and ultimately
resulting in early onset of aging (Bernal et al., 2014). A similar
mechanism is evident with epidermal growth factor signaling
dependent neural stem cell proliferation that is impaired by nitric
oxide produced in response to inﬂammation (Carreira et al.,
2014).
Additional pathways that impact cellular senescence through
metabolic regulation include the low energy-sensing systems of
AMPK and sirtuins (Houtkooper et al., 2010). Sirtuins (SIRT1-7)
are an enzyme family that play a signiﬁcant role in organismal
life-span (Mazzoccoli et al., 2014). SIRT1 aﬀects multiple
pathways and modulates telomere attrition, inﬂammation, SASP,
and premature senescence (Mercken et al., 2014). SIRT1
participates in maintenance of stem cell pool suppression and
regulates the diﬀerentiation of progenitor cells (Matsui et al.,
2012). Modulation of nutrient and energy-sensing mechanisms
is requisite for the regenerative capacity of aging stem cell
populations (Mazzoccoli et al., 2014).
Chronic Mitogenic Signaling
Similar to inﬂammation, chronic mitogenic signals are another
mechanism known to induce cellular senescence (Blagosklonny,
2003). For example, oncogenic induction was ﬁrst shown to
be prompted by a form of H-RAS that chronically triggered
a mitogen-activated protein kinase (MAPK) signaling pathway,
thereby transforming normal cells into senescent cells (Serrano
et al., 1997). Mitogenic signaling and the p16INK4a-Rb pathway
cooperate to enforce irreversible cellular senescence. (Takahashi
et al., 2006).
Dysfunctional Extracellular Matrix
Extracellular matrix (ECM) imparts strength and elasticity to
normal connective tissue by production of collagen ﬁbrils and
other extracellular components by ﬁbroblasts. When damaged,
for example in skin, it participates in chronological aging (as
well as photoaging from UV and sun exposure) by reducing
ﬁbroblast-ECM binding caused by collagen fragmentation (Quan
et al., 2013; Fisher et al., 2014). Conversely, injection of
cross-linked hyaluronic acid into the skin of aged individuals
stimulated ﬁbroblasts, and increased synthesis of Type I collagen
that helped to enhance mechanical force. This was evident in
the elongation and spreading of cells and indicates that decline
of mechanical support by the ECM contributes to the onset of
cellular senescence (Quan et al., 2013).
Now that we have described some of the diverse types of
subcellular damage (causes) that can trigger senescence, what
is the evidence that senescence itself causes an aged phenotype
(eﬀect)?
EVIDENCE THAT CELLULAR
SENESCENCE IS THE CAUSAL NEXUS
OF AGING
Various sources of evidence support the connection between
cellular senescence (loss of proliferation and SASP) and the
induction of organismal aging.
Correlation Between In Vitro Lifespan
and Species Lifespan
The replicative lifespans of mammalian ﬁbroblasts in vitro were
studied in a number of cell cultures representing eight species.
Senescence occurred at population doubling levels that were
characteristic for the species, and was shown to be related
to the species’ maximal lifespan by a strict power law, being
proportional to the square root of the maximal lifespan. In this
regard, “Based on data in the literature, the same relationship
was also valid for the lifespans of circulating mammalian
erythrocytes in vivo. These results may indicate the prevalence of
a common functional basis regulating the lifespan of ﬁbroblasts
and erythrocytes and thus operating in replicative as well as
postmitotic cells in vitro and in vivo” (Rohme, 1981). However,
it should also be noted that a later study of similar mammalian
species found that the replicative lifespan of ﬁbroblasts correlated
with the body mass of the species rather than the longevity,
which admittedly could be a factor confounding the correct
interpretation of the data (Lorenzini et al., 2005). Furthermore,
the authors were critical of the conclusions of the earlier work
(Rohme, 1981) because of the inclusion of embryonic and adult
ﬁbroblasts.
Progeroid Syndromes are Characterized
by Premature Senescence
The role of cellular senescence as the cause of aging is supported
by examining diseases of premature aging such as Hutchinson-
Gilford progeria syndrome (HGPS) and Werner’s syndrome
(WS) (von Zglinicki et al., 1995; Zindy et al., 1997; Saha et al.,
2013). Speciﬁc causative genes have been identiﬁed in both of
these syndromes. In humans, cells taken from patients with
both of these progeroid syndromes undergo far fewer divisions
than normal cells (Salk et al., 1981). Cellular senescence is likely
the key mechanism underlying the pathological conditions of
premature aging in both syndromes (Dominguez-Gerpe and
Araujo-Vilar, 2008). In human HGPS, cells exhibit a senescent
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phenotype including accumulation of Progerin that leads to
nuclear and mitotic abnormalities; the mouse model of HGPS
shows a relatively weaker eﬀect (Varga et al., 2006). Admittedly,
such ﬁndings could challenge the implication of pathways
participating in aging through arrest of cell proliferation and
onset of senescence (Miller, 2004), but it could be that Progerin
simply does not induce cellular senescence strongly in mouse
cells.
Senescent Cells Accumulate In Vivo in
Aging Organisms
Age-associated accumulation of senescent cells in various tissues
and organs causes functional disruption of tissue structure, partly
through appearance and accumulation of senescent-associated
secretory proteins (Coppé et al., 2008; Rodier and Campisi,
2011). Aging eﬀects have been detected in cells from multiple
mammalian species of various ages, including mice, baboons
and humans (Herbig et al., 2006; Jeyapalan et al., 2007; Wang
et al., 2009). A heterogeneous cell population showing a variable
proportion of senescent cells interspersed in islands of normal
cells is a common feature of aging mammalian tissues (Bahar
et al., 2006; Herbig et al., 2006). Variability in populations of
senescent cells in tissues can be explained by the fact that
onset of senescence is triggered by diverse factors that lead to
accumulation of molecular and physiological damage in cells
along with the exhaustion of their replicative potential (Shawi and
Autexier, 2008). Based on the tissue-speciﬁc variability of such
factors throughout the lifespan of the organism and the extent
of exposure to diﬀerent stressors in the habitat/environment of
the organism, a variable population of senescent cells in tissue
is a classic and characteristic feature of the progressive nature of
aging (Shawi and Autexier, 2008). In vitro, a negative correlation
between donor age and proliferative lifespan has been proposed
(Hayﬂick, 1965; Allsopp et al., 1992). Nevertheless, there are
also reports indicating that despite using controlled health status
and culture conditions, replicative lifespan in cultured ﬁbroblasts
does not correlate with donor age (Cristofalo et al., 1998).
Restoration of Telomeres and Cell
Proliferation Reverses the Aged
Phenotype
Restoration of telomerase activity can prevent replication-
dependent telomere attrition in vitro (Vaziri and Benchimol,
1998). Expression of exogenous human telomerase reverse
transcriptase (hTERT) has been achieved in a variety of cells
(Bodnar et al., 1998) and is known to counteract replicative
senescence by extending the proliferative lifespan (Simonsen
et al., 2002). This can circumvent the telomere-dependent
DNA damage signal and avoid induction of senescence (d’Adda
di Fagagna et al., 2003). Remarkably, similar reactivation
of telomerase in vivo in late generations of genetically
engineered telomerase-deﬁcient transgenic mouse strains (TERT-
ER) resulted in the extension of typically short telomeres and
reversed neurodegeneration and other degenerative features in
the spleen, intestine, and testes (Jaskelioﬀ et al., 2011). Similarly,
TA-65, a small molecule activator of telomerase, decreased
the percentage of critically short telomeres and increased
telomere length and lifespan in mice, without increasing cancer
incidence (Bernardes de Jesus et al., 2011). These ﬁndings
reinforce the signiﬁcance of telomerase activity in maintaining
chromosomal integrity, while also demonstrating that declining
activity represents an important factor contributing to the onset
of senescence and aging.
Removal of Senescent Cells Reverses
Aging
Instead of reversing senescence, as described above, actual
removal or “deletion” of senescent cells through genetic
manipulation in mice has been shown to yield reversal of age-
related symptoms in a tissue-speciﬁc manner, and to attenuate the
progression of established age-related symptoms when such cell-
clearance was induced later in the lifespan (Baker et al., 2011).
Similarly, “Senolytic” drugs that speciﬁcally kill senescent cells by
targeting pro-survival networks and making them susceptible to
apoptosis were observed to extend healthspan in mice (Zhu et al.,
2015).
Inhibition of Cell Proliferation Directly
Causes an Aged Phenotype
Recently, two crucial, seminal discoveries provide evidence that
aging can be induced in the absence of any molecular damage,
indicating that it is the senescent phenotype itself with its
inherent cessation of cellular proliferation and SASP that causes
aging, rather than biochemical or other intrinsic cues. This is
suggested by the recent and remarkable observations that in vivo,
tissue and organismal aging can be artiﬁcially forced to occur in
the absence of any accumulated molecular damage in only two
steps: (1) proliferative arrest followed by (2) organismal aging
(Pruitt et al., 2013; Boquoi et al., 2015).
Induced expression of p16INK4a in newborn and just-weaned
mice of transgenic strains with competence for conditional
p16INK4a expression revealed inhibition of proliferation and
accelerated emergence of aging features, including weight loss
and loss of subcutaneous fat, hair loss, wrinkled skinmorphology,
and cataracts (Boquoi et al., 2015). These symptoms were
abrogated in the mutant background of Cdk4 R24C, since this
strain is insensitive to kinase inhibitors. These data conﬁrm
that conditional p16INK4a expression results from Cdk inhibition
(Boquoi et al., 2015).
Likewise, conditional induction of the Cdk inhibitor Cdkn1b
or p27kip1 caused either complete loss or signiﬁcant decline
of somatic cell proliferation in multiple tissues and induced
premature aging features in the absence of any detectable
naturally senescent cells in aged tissue (as opposed to the
artiﬁcially blocked cellular proliferation) or activation of any
DDR pathways (Pruitt et al., 2013).
Caloric Restriction Decreases Senescent
Cells
Caloric restriction (CR) is one of the few demonstrably eﬀective
modalities shown to be capable of slowing down aging in almost
all species. But how is this accomplished? It is likely that it
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works at least in part by suppressing cellular senescence. For
example, temporary dietary restriction in middle-aged mice has
been successful in decreasing the number of senescent cells in the
liver and intestine (Wang et al., 2009, 2010). Markers of cellular
oxidative damage decrease in cells in which senescence was noted,
as well as in calorically restricted mice (Kirkland, 2010).
Species-speciﬁcity of rodents in response to CR has been
shown in controlled laboratory conditions, where CR increased
the median life-span of rats by 14–15%. In mice the ﬁnding was
much weaker, ranging from 4 to 27%, with inbred strains showing
the least eﬀect in comparison to outbred strains, indicative of
genotype dependence (Swindell, 2012). Experimental evidence
further indicates that CR is more eﬀective in males, as well
as in standard model organisms used for experiments than
in non-model organisms. These ﬁndings are indicative of
convergent adaptation in laboratory conditions (Nakagawa et al.,
2012).
Viruses and Drugs that Exhaust Cell
Proliferation are Associated with an
Aging Phenotype
The existence of cancer has been evident in fossil records
prior to emergence of homo sapiens on the earth (Dunn,
2012). Multiple co-morbidities due to cancer, and particularly
its chemotherapeutic treatment, are augmented in aging cancer
survivors, who have a rate of frailty akin to older adults
(Avis and Deimling, 2008; Ness et al., 2013; Henderson et al.,
2014). Notably, anticancer drug treatment induces apoptosis in
hair follicles leading to hair loss in treated patients through
senescence associated p53 mediated pathways (Botchkarev
et al., 2000). Similarly, a blockade of cell-proliferation by the
alopecia-causing chemotherapeutic drug cyclophosphamide is
evident: it down-regulates Sonic Hedgehog (Shh) transcription,
thereby aﬀecting the Shh-dependent proliferation pathway
in actively proliferating epithelial cells (Xie et al., 2015).
Likewise, the mechanism of action of most chemotherapeutics
is such a blockage of cell division, which has a pro-aging
eﬀect.
It is highly likely that infection with retroviruses such as
HIV and the side-eﬀects of antiretroviral drugs accelerate the
senescence of cells, which in turn leads to premature aging.
Notably, age-associated co-morbidities due to diabetes,
cardiovascular conditions, frailty, and neurocognitive
impairment are more prevalent in HIV-infected individuals
of all ages than those without infection (Pathai et al., 2014). For
example, a comparative analysis on the brains of HIV-infected
and non-infected controls using Magnetic Resonance
FIGURE 6 | Damage leads to causal nexus leads to effects. In different species the causes of cellular senescence may be similar, but have different
magnitudes. For example, in mice (A) DNA damage/Tumor suppressor activation may be a major factor, whereas in humans (B), telomere erosion may have a
greater effect because humans have much shorter telomeres than mice. In both species, accrued, and unrepaired damage to the cellular genome, epigenome, and
organelles (causes) is finally manifested in the visible phenotype, evident as aged features of the organism, such as organ dysfunction, loss of structural integrity, and
physiological and anatomical changes (effect). The link between cause and effect, the causal nexus, is cellular senescence. Additionally, it has been shown that in
mice, blocking cell division alone, in the absence of any molecular damage, can induce premature Progeria-like aging.
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Imaging and a series of neuropsychological tests revealed
acceleration of the normal aging trajectory in higher-order
cognition regions of brains of infected individuals, despite
absence of any detectable symptoms of dementia (Pfeﬀerbaum
et al., 2014). It has been postulated that a comparative analysis
of HIV-associated lipodystrophy with genetic lipodystrophy as
well as those associated with monogenic laminopathies might
reveal the shared pathways leading to disorders of adipose
distribution and the eﬀects of drugs and therapeutic approaches
used to treat infection (Freitas and Carvalho, 2013). Based on
increasing evidence of premature aging after successful HIV
treatment, analysis of the mechanism of nucleoside analog anti-
retroviral drugs revealed progressive accumulation of somatic
mitochondrial mutations akin to the accumulation evident in
the late stage of life as a result of normal aging (Payne and
Chinnery, 2015). Also, a comparative analysis of methylation
levels of peripheral blood mononuclear cells in age-matched
HIV-1 infected and uninfected individuals revealed that HIV-
1 infection accelerated age-related methylation by 13–14 years,
thereby indicating that HIV-1 associated aging shares the same
functional and epigenetic changes associated with normal aging
(Rickabaugh et al., 2015).
The ﬁndings cited indicate that pathological conditions and
infections as well as their therapeutic interventions contribute to
senescence regardless of biological age.
SUMMARY AND CONCLUSION
Aging is a complex, multifaceted, and multidimensional state,
with a variable course of progression. This work represents a
compilation of themost recent ﬁndings in support ofWeismann’s
original hypothesis that the initial decline and cessation of the
proliferative ability of fatigued, damaged, and dysfunctional cells
is the ultimate cause of aging. Following the principle of cause
and eﬀect, our model demonstrates how replicative senescence,
ﬁrst referred to as the Hayﬂick response, allows several competing
aging theories to coexist and converge. At the same time, it
encompasses Weismann’s predictions of complementary mortal
(soma) and immortal (germ) cell types to account for a capacity
for inﬁnite renewal juxtaposed against mortality. By integrating
the wisdom of many great minds, we propose a slightly evolved
model that not only accurately describes the data, but also
enables a complete understanding of the interactions between the
mechanisms at play over the course of aging.
Since aging is a progressive condition that steadily advances
from invisible to visible and localized to ubiquitous, the central
question as to the direct cause of the entire process is key.
The answer has been elusive due to its complex nature. Our
model proposes that the process of aging results from a
sequential passage through three distinct phases and can be
described by the following blueprint: (1) molecular damage
which results in (2) cessation of proliferation leading to cellular
senescence followed by (3) body-wide aging of the organism
(Figure 6). The ﬁrst step occurs when localized, microscopic
damage accumulates to a point where the burden to repair
overwhelms the system. Despite the tissue source or broad input
of molecular damage, crossing of this threshold results in the
second phase, the crux of the entire process – arrest of cellular
proliferation, acquisition of the SASP, and imminent cellular
senescence. Once this occurs, the third phase of aging begins.
This ﬁnal phase is marked by tissue dysfunction and breakdown
that results in the visible signs of comprehensive organismal
aging.
In diﬀerent species, the causes of cellular senescence may
be similar, but have diﬀerent magnitudes (Figure 6). This may
help explain why aging studies in diﬀerent species are not
always comparable and thus can be diﬃcult to interpret. For
example, in mice (Figure 6A) DNA damage/tumor suppressor
activation may be a major factor, whereas in humans (Figure 6B),
telomere erosion may have a greater eﬀect because humans
have much shorter telomeres than mice. Nevertheless, in both
species, accrued and unrepaired damage to the cellular genome,
epigenome, and organelles (causes) is ﬁnally manifested in the
visible phenotype, evident as aged features of the organism,
such as organ dysfunction, loss of structural integrity, and
physiological and anatomical changes (eﬀect). Therefore, the link
between cause and eﬀect, the causal nexus, is cellular senescence.
The incremental advance proposed by our model is that
while there are many undisputed factors that trigger the onset
of cellular senescence and result in cessation of proliferation
and SASP, the ﬁrst phase in the model (cumulative molecular
damage) is a precursor, rather than a ﬁnal cause of aging.
The complexity normally imposed by countless variables (i.e.,
age of onset, site of damage, aﬀected cell type, mechanism
of damage, and even species) that need to be overcome is
rendered manageable by eliminating the ﬁrst phase in the
aging schematic. And since organismal aging can be artiﬁcially
and reversibly induced by blocking and restarting cellular
proliferation, this indicates that the second phase in the model –
cessation of proliferation followed by cellular senescence – clearly
represents the essential cause of aging. Placing cellular senescence
in the pivotal junction between cause and eﬀect, the causal
nexus, to yield an integrated model of aging will serve to
advance identiﬁcation of crucial targets for future therapeutic
investigation. By identifying cellular senescence as the causal
nexus of aging, the process of treating, reversing and possibly
even eventually eliminating this once inevitable outcome draws
closer to reality.
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